StockData
VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

VYCOR MEDICAL INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.07+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$2.24M
P/E (TTM)
–
Dividend yield
–

About Vycor Medical

Surgical & Medical Instruments & Apparatus, SIC 3841

Vycor Medical, Inc. operates within the medical device industry across two distinct divisions: Vycor Medical and NovaVision. The Vycor Medical division designs, develops, and commercializes medical devices tailored for neurosurgery, featuring its ViewSite Brain Access System for surgical access and retraction during brain and spine procedures. NovaVision supplies computer-based, non-invasive rehabilitation therapies designed for patients suffering from visual impairments caused by neurological brain trauma, such as strokes, utilizing products like Vision Restoration Therapy and NeuroEyeCoach.

The company maintains corporate headquarters in Boca Raton, Florida, where it leases office facilities. Its medical devices and rehabilitation products hold regulatory clearances and registrations across several international markets, including the United States, Europe, and Canada. Vycor Medical employs a workforce of seven personnel and markets its surgical solutions and therapeutic platforms internationally through direct channels, distribution networks, and strategic commercial partnerships.

Summary of the business section of Vycor Medical's latest annual report, written by StockData.

Company profile

Company

Legal name
VYCOR MEDICAL INC
Founded
2005
Headquarters
Boca Raton,, FL
Address
951 Broken Sound Parkway, Suite 320 33487
Phone
(562) 558-2000
Employees
7, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Prager Metis CPAs, LLC, Hackensack, New Jersey

Stock & identifiers

Ticker
VYCO
Exchange
OTC
Shares outstanding
33M, Aug 14, 2026
Public float
$1.71M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-150 reverse, Apr 1, 2013
SEC CIK
1424768
EIN
20-3369218

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Vycor Medical's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“We currently have 7 employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Mar 31, 2025Late filingNotification of late filing
Apr 1, 2024Late filingNotification of late filing
Mar 31, 2023Late filingNotification of late filing
Apr 1, 2022Late filingNotification of late filing
Aug 17, 2020Late filingNotification of late filing
Oct 12, 2018Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 28, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 31, 2014Late filingNotification of late filing
Nov 14, 2013Late filingNotification of late filing
Aug 15, 2011Late filingNotification of late filing
Feb 14, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 3, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 27, 2010ListingRegistration of securities on an exchange (Form 8-A)
Nov 16, 2009Late filingNotification of late filing
Mar 31, 2009Late filingNotification of late filing